Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

REFERENCES

• Blom G. Statistical estimates and transformed beta variables. John Wiley and Sons Inc, , NY 1958; 1–58
   Google Scholar
• Chavanet P., Joly V., Rigaud D., Bolard J., Carbon C., Yenni P. Influence of diet on experimental toxicity of amphotericin B deoxycholate. Antimicrob. Agents Chemother 1994; 38: 963–968
   PubMed Web of Science ®Google Scholar
• Dangi J. S., Vyas S. P., Dixit V. K. Effects of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev. Ind. Pharm 1998; 24: 631–635
   PubMed Web of Science ®Google Scholar
• Egito E. S. T., Araujo I. B., Bolivar P. G., Damasceno L., Price J. C. Amphotericin B/Emulsion admixture interactions: An approach concerning the reduction of amphotericin B toxicity. J. Pharm. Sci 2002; 91: 2354–2366
   PubMed Web of Science ®Google Scholar
• Fagerholm U., Johansson M., Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res 1996; 13: 1336–1342
   PubMed Web of Science ®Google Scholar
• Gates C., Pinney R. J. Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther 1993; 18: 147–153
   PubMed Web of Science ®Google Scholar
• Hauss D. J., Fogal S. E., Ficorilli J. V., Price C. A., Roy T., Jayaraj A. A., Kerns J. J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci 1998; 87: 164–169
   PubMed Web of Science ®Google Scholar
• Holm R., Porter C. J., Mullertz A., Kristensen H. G., Charman W. N. Structured triglycerides vehicles for oral delivery of halofantrine: Examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm. Res 2002; 19: 1354–1361
   PubMed Web of Science ®Google Scholar
• Kararli T. T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos 1995; 16: 351–380
   PubMed Web of Science ®Google Scholar
• Lance M. R., Washington C., Davis S. S. Structure and toxicity of amphotericin B/triglyceride emulsion formulations. J. Antimicrob. Chemother 1995; 36: 119–128
   PubMed Web of Science ®Google Scholar
• Levet-Trafit B., Gruyer M. S., Marjanovic M., Chou R. C. Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sci 1996; 58: PL359–363
   PubMed Web of Science ®Google Scholar
• Manfredi R., Chiodo F. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS. Pharmacotherapy 1998; 18: 1087–1092
   PubMed Web of Science ®Google Scholar
• Marr K. A., Balajec S. A., McLaughlin L., Tabouret M., Bentsen C., Walsh T. J. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables the affect performance. J. Infect. Dis 2004; 190: 641–649
   PubMed Web of Science ®Google Scholar
• Meyer R. D. Current role of therapy with amphotericin B. Clin. Infect. Dis 1992; 14: S154–S160
   PubMed Web of Science ®Google Scholar
• Porter C. J., Charman W. N. Intestinal lymphatic drug transport: An update. Adv. Drug Deliv. Rev 2001; 50(1–2)61–80
   PubMed Web of Science ®Google Scholar
• Reymond J. P., Sucker H., Vonderscher J. In vivo model for ciclosporin intestinal absorption in lipid vehicles. Pharm. Res 1988; 5: 677–679
   PubMed Web of Science ®Google Scholar
• Risovic V., Boyd M., Choo E., Wasan K. M. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob. Agents Chemother 2003; 47(10)3330–3342
   Google Scholar
• Risovic V., Sachs-Barrable K., Boyd M., Wasan K. M. Potential Mechanisms by which Peceol increases gastrointestinal absorption of Amphotericin B. Drug Dev. Ind. Pharm 2004; 30(7)767–774
   PubMed Web of Science ®Google Scholar
• Sivak O., Bartlett K., Risovic V., Choo E., Marra F., Batty D. S., Wasan K. M. Assessing the antifungal activity and toxicity profile of Amphotericin B Lipid Complex (ALBC; Abelcet®) in combination with Caspofungin in experimental systemic aspergillosis. J. Pharm. Sci 2004; 93(6)1382–1389
   PubMed Web of Science ®Google Scholar
• Soria I., Zimmerman C. L. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharm. Drug Dispos 1996; 17: 817–818
   PubMedGoogle Scholar
• Souza L. C., Campa A. Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion. J. Antimicrob. Chemother 1999; 44: 77–84
   PubMed Web of Science ®Google Scholar
• Souza L. C., Maranhao R. C., Schreier S., Campa A. In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion. J. Antimicrob. Chemother 1993; 32: 123–132
   PubMed Web of Science ®Google Scholar
• Souza L. C., Saldiva P. H., Campa A. Lipid emulsion reduces subacute toxicity of amphotericin B: A histopathological study. Exp. Toxicol. Pathol 2000; 52: 169–175
   PubMed Web of Science ®Google Scholar
• Wasan K. M. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Dev. Ind. Pharm 2002; 28: 1047–1058
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Grossie V. B., Jr., Lopez-Berestein G. Concentrations in serum and tissue distribution of free and liposomal amphotericin B in rats on continuous Intralipid infusion. Antimicrob. Agents Chemother 1994; 38: 2224–2226
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Kennedy A. L., Cassidy S. M., Ramaswamy M., Holtorf L., Chou J. W. L., Pritchard P. H. Pharmacokinetics, Distribution in Serum Lipoprotein and Tissues and Renal Toxicities of Amphotericin B and Amphotericin B Lipid Complex in a Hypercholesterolemic Rabbit Model: Single Dose Studies. Antimicrob. Agents Chemother 1998; 42: 3146–3152
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Vadiei K., Lopez-Berestein G., Luke D. R. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J. Infect. Dis 1990; 161: 562–566
   PubMed Web of Science ®Google Scholar